Current Report Filing (8-k)
March 21 2023 - 3:10PM
Edgar (US Regulatory)
0001715819
false
0001715819
2023-03-15
2023-03-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): March 15, 2023
ELECTROMEDICAL TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified
in its Charter)
| Delaware |
Commission File Number |
82-2619815 |
(State or other jurisdiction of
incorporation or organization) |
000-56192 |
(I.R.S. Employer
Identification Number) |
16561 N. 92nd Street, Ste. 101
Scottsdale, AZ 85260
(Address of Principal Executive Offices
and Zip Code)
888-880-7888
(Issuer's telephone number)
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| ¨ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| ¨ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| ¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
Section 1 - Registrant’s Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
On March 15, 2023, the Registrant and Care National
Healthcare Services, Inc. ("Care National") closed a material definitive agreement. Pursuant to the terms of the agreement,
the Registrant sold its real property located at 16561 N. 92nd Street, Ste. 101, Scottsdale, AZ 85260, to Care National in exchange for
a purchase price of $2,000,000.00, with net proceeds to the Registrant of $1,358,710.56. But for the material definitive agreement, no
relationship exists between the Registrant and Care National.
The closing of the purchase and sale agreement
extinguishes the Registrant's mortgage debt on the property, along with all outstanding principal and interest.
Concurrent with the sale and purchase agreement closing, the Registrant
and Care National entered into a commercial lease for the Registrant's current office located at 16561 N. 92nd Street, Unit D101, Scottsdale,
AZ 85260, where the Registrant will maintain its executive offices. The term of the lease is one year. The monthly rent is $9,000 per
month.
Section 2 - Financial Information
Item 2.01 Completion of Acquisition or Disposition of Assets.
The disclosures set forward in Item 1.01 are incorporated herein by
reference.
Section 9 – Financial Statement and Exhibits
Item 9.01 Financial Statements and Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated March 21, 2023
ELECTROMEDICAL TECHNOLOGIES, INC.
| By: |
/s/ Matthew Wolfson |
|
| Matthew Wolfson |
| Chief Executive Officer |
| (Principal Executive Officer) |
ElectroMedical Technolog... (PK) (USOTC:EMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
ElectroMedical Technolog... (PK) (USOTC:EMED)
Historical Stock Chart
From Apr 2023 to Apr 2024
